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in	 both	 groups	 at	 both	 times.	We	 conclude	 that	 for	 lactating	women	 an	 adequate	
amount	of	appropriately	iodized	salt	(30–40	μg	I/g)	had	similar	effects	as	a	daily	sup-
plement	of	225	μg	I	on	BMIC	and	on	maternal	and	infant	UIC.








damage	 to	 the	 offspring	 (Halpern	 et	al.,	 1991;	 Pharoah,	 Buttfield,	 &	
Hetzel,	 1971).	 Mild-	to-	moderate	 iodine	 deficiency	 may	 result	 in	 re-
duced	 learning	 ability,	 and	 increased	 risk	 of	 low	birth	weight	 and	of	
infant	morbidity	and	mortality	(Zimmermann,	2009).	Infants	under	two	
years	of	age	are	among	the	most	vulnerable	groups	to	be	affected	by	




Risk	 of	 iodine	 deficiency	 in	 early	 infancy	 is	 high	 even	 in	 iodine	
sufficient	 areas	 because	 infant	 intrathyroidal	 reserve	 turnover	 rate	
is	 rapid	 (Delange,	1998).	Therefore,	 in	 iodine	 insufficient	 areas,	 rec-
ommendations	for	iodine	for	women	during	pregnancy	and	lactation	
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are	 increased	 to	 250	μg/day	 or	 to	 a	 400	mg	 single	 annual	 dose	 of	
iodized	 oil	 supplement	 (Andersson,	 de	 Benoist,	 Delange,	 &	 Zupan,	
2007).	Because	a	large	amount	of	iodine	is	secreted	into	breast	milk,	
exclusively	breastfed	 infants	0–6	months	of	 age	 should	 receive	 suf-













(Institute	of	Medicine	2001).	 Iodine	 intake	greater	 than	 the	 require-
ment	generally	will	be	excreted	in	the	urine	(Zimmermann,	2007).
BMIC	 can	 be	 increased	 by	 increasing	 maternal	 iodine	 intake	
(Zimmermann,	2007).	In	a	study	in	16	healthy	lactating	US	women,	the	
BMIC	was	significantly	 increased	by	a	one-	time	 ingestion	of	600	μg 
potassium	 iodide	 (456	μg	of	 iodine)	with	peak	 levels	 at	6	hr	 (Leung,	
Braverman,	He,	Heeren,	&	 Pearce,	 2012).	 In	 a	 randomized,	 double-	
blind,	placebo-	controlled	study,	supplementation	to	lactating	women	
of either 75 μg/day	or	150	μg/day	of	 iodine	as	potassium	 iodate	 for	
6	months	 significantly	 increased	 the	BMIC	 and	maternal	 urinary	 io-
dine	 concentration	 (UIC).	However,	 the	 amount	of	 supplementation	
given	was	not	 sufficient	 to	 improve	 the	mothers’	or	 infants’	 thyroid	
hormones	 (Mulrine,	 Skeaff,	 Ferguson,	 Gray,	 &	Valeix,	 2010).	 In	 an-
other	double-	blind,	randomized,	placebo-	controlled	trial,	one	dose	of	






















2  | MATERIALS AND METHODS
2.1 | Data source and study population
The	 study	was	conducted	 in	 rural	 areas	of	Sidama	zone,	 southern	
Ethiopia.	 All	 lactating	 women	 (n	=	101)	 in	 the	 randomly	 selected	
study	villages	who	delivered	between	January	and	February,	2013	
were	 recruited	 within	 a	 week	 after	 delivery	 to	 participate	 in	 the	
study.	 Informed	consent	was	obtained	from	the	women	for	 them-
selves	and	for	their	infants.	This	study	was	conducted	in	accordance	
with	 the	 ethical	 principles	 for	 the	 protection	 of	 human	 subjects.	
Ethical	 approval	 was	 obtained	 from	 Oklahoma	 State	 University	








Mean	 iodine	concentration	of	 the	 salt	manufactured	 for	 this	 re-
search	project	was	verified	by	inductively	coupled	plasma	mass	spec-
trophotometry	(ICP-	MS,	Elan	9000,	Perkin-	Elmer,	Norwalk,	CT)	to	be	
35.1	 (3.6)	 μg/g,	 consistent	with	 the	 recommendation	 (20–40	mg	 of	









use	salt	 from	the	 local	market	until	 the	end	of	the	study	and	not	to	











pre-	tested	 questionnaire	 was	 administered	 to	 assess	 the	 socioeco-
nomic	 and	 demographic	 characteristics	 including	 household	 size	 of	
the	mothers	participating	in	the	study.
Before	 delivery	 of	 supplements,	 baseline	 data	 including	 anthro-
pometry,	urine	 samples,	breast	milk	 samples,	 and	sociodemographic	
information	were	 collected	 from	mothers.	 Infant	 urine	 samples	 also	





Ten	mL	 of	 breast	milk	was	 collected	 from	 each	mother	 in	 plastic	
cups	and	 stored	 in	 tightly	 capped	vials.	Breast	milk	 samples	were	
collected	between	9:00	and	11:00	AM.	Samples	were	frozen	until	





(Perkin-	Elmer,	 Waltham,	 MA).	 After	 cooling	 to	 room	 tempera-
ture,	 the	 samples	 were	 centrifuged	 at	 1,532	 x	 g	 for	 15	minutes.	
For	analysis,	all	breast	milk	samples	were	diluted	25-	fold	with	5%	
TMAH	 (Sigma-	Aldrich,	 St.	 Lowis,	 MO)	 in	 deionized	 water.	 BMIC	
was	analyzed	by	 ICP-	MS	(Fecher,	Goldmann,	&	Nagengast,	1998).	















the	 iodine	 content	 in	 the	water	was	 assayed.	 Iodine	 content	 in	 the	
water	was	below	the	detection	limit	of	1	μg/L.
Samples	were	 frozen	 at	 −20°C	 at	Hawassa	University	 and	 then	
transported	 to	 OSU	 for	 analysis.	 Urinary	 iodine	 was	 diluted	 in	 2%	
ammonium	hydroxide	and	analyzed	by	ICP-	MS,	with	tellurium	as	 in-
ternal	 standard	 (Caldwell	 et	al.,	 2003).	 Quality	 control	 samples	 for	
urinary	 iodine	were	measured	 every	 10	 samples	 to	 ensure	 stability	
of	the	instrument.	Urinary	creatinine	was	analyzed	using	a	BioLis	24i	
clinical	 chemistry	 analyzer	 with	 standard	 reagents	 (Carolina	 Liquid	
Chemistries	Corp.,	Brea,	CA).






Drinking	water	 samples	were	 collected	 from	 each	 of	 the	 study	











Associations	 between	 outcome	 variables	 were	 assessed	 using	
Spearman’s	 correlation	 analysis.	The	 relation	between	multiple	vari-
ables	and	infant	UIC	were	modeled	using	stepwise	linear	regression.
Data	are	reported	as	mean	(SD),	median	with	 interquartile	range	
[IQR],	or	frequency	(%)	as	appropriate.	Significance	was	set	at	p < .05. 
SPSS	 (version	 20;	 IBM	 Corp.	 Armonk)	 and	 SAS	 (Version	 9.3;	 SAS	
Institute	Inc.,	Cary,	NC)	were	used	for	data	analyses.
3  | RESULTS
















3.2 | Breast milk and urinary iodine concentration of 
mothers and their infants
Table	2	shows	baseline	and	6	months	concentrations	and	distribu-
tions	of	BMIC	and	of	UIC	of	mothers	and	their	infants.	The	women	
were	not	 significantly	different	 in	BMIC	or	UIC	by	 treatment	 and	
the	 infants	were	 not	 significantly	 different	 in	 the	UIC	 at	 the	 two	
time	 points	 for	 either	 treatment.	 To	 better	 understand	 effects	 of	
daily	 iodine	 supplementation,	we	 categorized	BMIC	 into	different	
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groups.	At	the	end	of	the	study	at	6	months	36%	of	the	women	had	
BMIC	<	60	μg/L,	 18%	 had	 60–120	μg/L,	 29%	 had	 120–240	μg/L	
















Among	 the	 salt	 samples	 tested	 21%	met	 the	minimum	 recommen-












all	 four	 predictors	 produced	 an	 adjusted	R2	=	.290	 and	 at	 6	months	
the	model	adjusted	R2	was	.316.	At	baseline	maternal	UIC/creatinine,	





Capsule group I- salt group
Mothers Baseline 6 months Baseline 6 months
BMIC	(μg/L)b 149	[46,	266] 104	[39,	197] 157	[29,	243] 111	[34,	202]
BMIC	<	120	(μg/L)c 40% 56% 39% 53%
UIC	(μg/L) 136	[76,	173] 150	[86,	220] 95	[64,	142] 110	[73,	191]
UIC	<	100	(μg/L) 42% 32% 53% 45%
I/Cre	(μg/g) 214	[142,	292] 176	[126,	383] 203	[139,	268] 173	[117,	292]
Infants
UIC	(μg/L) 234	[121,	379] 254	[130,	400] 193	[107,	331] 195	[108,	352]
UIC	<	180	μg/Ld 40% 38% 49% 47%
UIC	<	100	μg/L 16% 8% 18% 24%
aData	are	median	[IQR]	or	percentage.
bBMIC,	 breast	 milk	 iodine	 concentration;	 UIC,	 urinary	 iodine	 concentration;	 Cre,	 creatinine;	 I-	salt	
group,	iodized	salt	group.
cBMIC	≥	120	μg/L	is	assumed	to	provide	the	infant’s	daily	requirement	of	90	μg	(Zimmermann,	2007).
dInfant	UIC	≥	180	μg/L	 represents	 the	 expected	UIC	 output	 in	 the	 neonates	 and	 infants	when	 the	








group (n = 50)
I- Salt group 
(n = 51) p- value
Mothers
Age	(years) 23	[20,	27] 21	[20,	25] .14
MUAC	(cm) 23.2	(1.8) 23.3	(1.7) .62
BMI	(kg/m2) 21.2	(2.5) 21.8	(2.0) .15
Gravidity 2	[1.75,	4] 2	[1,	5] .41
Parity 2	[1,	4] 2	[1,	4] .38
School	years 2	[2,	3] 2	[1,	3] .42














Data	are	median	 [IQR],	mean	 (SD),	%	 (n/N).	Group	mean	difference	was	
analyzed	using	T-	test	or	Mann-	Whitney	U	test,	and	the	categorical	variable	
(sex)	 was	 analyzed	 using	 the	 Chi-	square	 test,	 p	<	.05	 was	 considered	
significant.





nificantly	different	between	mothers	who	received	225	μg of iodine 
daily	as	a	capsule	for	6	months	in	addition	to	variable	amounts	of	io-




























normal	range	of	150–180	μg/L	 in	 iodine	sufficient	countries	 (Dorea,	




women	 in	New	Zealand	was	 lower,	Mulrine	et	al.	 (2010)	 found	 that	
BMIC	declined	over	 the	 first	24	weeks	 in	non-	supplemented	 lactat-
ing	women	and	supplementation	with	75	μg or 150 μg	of	iodine	daily	
did	not	increase	BMIC	to	a	level	that	could	raise	infant	median	UIC.	
In	 the	 women	 who	 received	 75	μg	 of	 iodine	 for	 24	weeks,	 BMIC	
ranged	 between	 35	 to	 57	μg/L	 and	median	 infant	UIC	was	 50	 [22,	
60]	μg/L.	 In	the	group	who	received	150	μg,	BMIC	ranged	between	





It	 should	 be	 noted	 that	 our	 baseline	 data	were	 collected	within	
1	week	(with	more	than	32%	within	4	days)	after	delivery,	when	some	
colostrum	was	still	available.	Iodine	concentration	is	high	in	colostrum	
and	decreases	over	 time,	which	could	 contribute	 to	BMIC	decrease	




et	al.,	 1988,	WHO	1998).	However,	 because	 the	decrease	 in	 iodine	
concentration	in	breast	milk	over	time	has	not	been	measured	in	detail,	
it	 is	difficult	 to	quantify	 the	effect	our	 supplementation	had	on	 the	
usual	decrease	in	BMIC	from	colostrum	to	mature	milk.
A	 study	 conducted	 at	 a	 time	 when	 only	 4.2%	 of	 households	
in	 Ethiopia	 consumed	 iodized	 salt	 reported	 BMIC	 in	 the	 range	 of	
5–16 μg/L	 (Abuye	 &	 Kelbessa,	 2000).	 Our	 data	 collected	 after	 the	
policy	 that	 all	 salt	 should	be	 iodized	 showed	a	wide	 range	 in	BMIC	






or	 iodine	 capsule	 and	 no	 adverse	 reaction	 was	 reported	 in	 any	 of	
the	study	participants.	 In	a	study	of	50	Korean	women,	whose	diets	
Variables
At baseline At 6 months
β 95% CI p β 95% CI p
Maternal	UIC/ 
Creatinine	(μg/g)
0.30 0.15,	0.64 .002 0.42 0.26,	0.65 .000
BMIC	(μg/L) 0.26 0.05,	0.29 .006 0.27 0.06,	0.28 .003
Infant’s	age	(days) −0.16 −0.05,	0.003 .083 0.12 −0.01,	0.07 .167



























29%	at	 6	months	 had	BMIC	<	120	μg/L,	which	 is	 the	 concentration	












between	1	μg/L	 to	89	μg/L)	 (Abuye	&	Kelbessa,	 2000;	Bogale	 et	al.,	
2009;	 Ersino	 et	al.,	 2013;	 Gebreegziabher	 et	al.,	 2013;	 Girma	 et	al.,	
2012).	Therefore,	the	higher	UIC	observed	at	baseline	in	this	study	can	
be	attributed	 to	 the	salt	 iodization	program	that	began	to	be	 imple-
mented	in	2012	in	the	country	(Ethiopian	Public	Health	Institute	2014).
The	 proportion	 of	 women	with	 UIC	 below	 100	μg/L	 decreased	
from	42%	to	32%	in	the	capsule	group	and	from	53%	to	45%	in	the	
I-	salt	 group	 between	 baseline	 and	 the	 end	 of	 the	 study.	A	 double-	
blind,	 randomized,	 placebo-	controlled	 study	 in	Morocco	 reported	 a	
14%	increase	 in	UIC	at	6	months	after	giving	the	 lactating	mother	a	
400	mg	iodized	oil	capsule	(Bouhouch	et	al.,	2014).	The	study	in	New	









lactating	mothers	and	90	μg	of	 iodine	daily	 for	neonates	and	 infants	




study	at	baseline	was	 relatively	high	 (218	μg/L)	 compared	with	data	
reported	from	three	of	four	iodine	sufficient	countries	(Zimmermann,	
2007).	 However,	 despite	 the	median	 UIC	 of	 218	μg/L	 in	 our	 study,	
17%	of	the	 infants	at	baseline	and	16%	at	6	months	had	UIC	below	
100 μg/L.
The	median	 infant	UIC	 at	 baseline	was	 significantly	 higher	 than	
BMIC	 (p	<	.001)	 and	maternal	UIC	 (p	<	.001)	 and,	 although	 not	 sig-
nificant,	median	BMIC	 tended	 to	be	higher	 than	maternal	UIC.	This	






The	 correlation	 between	 maternal	 UIC	 and	 BMIC	 increased	
when	maternal	UIC	was	adjusted	for	creatinine.	A	study	conducted	





adjusted	 for	 creatinine	 (Haddow,	McClain,	 Palomaki,	 &	 Hollowell,	
2007).
In	our	 regression	model	 for	 infant	UIC	at	baseline,	maternal	uri-




We	 did	 not	 analyze	 iodine	 content	 of	 complementary	 foods.	
When	 complementary	 feeding	 is	 begun,	 breast	 milk	 consumption	





do	 not	 buy	 foods	 from	outside,	 iodized	 salt	 is	 a	 critical	 source	 of	
iodine	 for	 the	 study	 population.	 As	 infants	 begin	 to	 get	 a	 higher	
percent	of	energy	from	low	iodine	complementary	foods,	their	total	
iodine	 intake	will	go	down.	 In	the	study	region	 (Southern	Nations,	
Nationalities	 and	 Peoples’	 Region),	 the	median	 duration	 of	 exclu-
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CONCLUSIONS
In	 conclusion,	 our	 findings	 suggest	 that	 salt	 iodized	 at	 the	 recom-






As	 a	 way	 to	 combat	 iodine	 deficiency	 disorders,	 universal	 salt	
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